Holen Sie sich die Stockscreener-App
49.41
3.68%
-1.89
Handel nachbörslich:
49.41
Schlusskurs vom Vortag:
$51.30
Offen:
$51.19
24-Stunden-Volumen:
2.13M
Relative Volume:
1.78
Marktkapitalisierung:
$7.55B
Einnahmen:
$3.24B
Nettoeinkommen (Verlust:
$304.90M
KGV:
22.77
EPS:
2.17
Netto-Cashflow:
$156.70M
1W Leistung:
-12.78%
1M Leistung:
-20.88%
6M Leistung:
-34.18%
1J Leistung:
-19.37%
1-Tages-Spanne:
$48.85
$51.49
1-Wochen-Bereich:
$48.85
$57.10
52-Wochen-Spanne:
$48.85
$94.86
Bruker Corp Stock (BRKR) Company Profile
Firmenname
Bruker Corp
Sektor
Branche
Telefon
978663-3660
Adresse
40 MANNING RD, BILLERICA, MA
Vergleichen Sie BRKR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| BRKR | 49.41 | 7.55B | 3.24B | 304.90M | 156.70M | 2.17 |
| ABT | 117.36 | 202.64B | 41.22B | 5.77B | 6.49B | 2.94 |
| SYK | 389.40 | 150.72B | 21.97B | 3.59B | 3.21B | 6.74 |
| BSX | 90.45 | 133.82B | 15.91B | 1.79B | 1.89B | 0.82 |
| MDT | 87.59 | 112.98B | 32.58B | 3.93B | 5.15B | 2.71 |
| EW | 69.89 | 40.52B | 6.60B | 4.16B | 490.10M | 2.34 |
Bruker Corp Stock (BRKR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-02-14 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-12-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2022-10-21 | Eingeleitet | UBS | Buy |
| 2022-08-22 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-10-15 | Fortgesetzt | Cowen | Market Perform |
| 2021-06-15 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2021-02-05 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-12-02 | Eingeleitet | Goldman | Sell |
| 2020-11-16 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2020-05-01 | Herabstufung | Cleveland Research | Buy → Neutral |
| 2020-04-02 | Herabstufung | Wolfe Research | Peer Perform → Underperform |
| 2020-04-01 | Herabstufung | Needham | Strong Buy → Hold |
| 2020-03-26 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Hold |
| 2019-09-26 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-07-15 | Hochstufung | Goldman | Sell → Neutral |
| 2019-06-24 | Bestätigt | Needham | Strong Buy |
| 2019-06-21 | Bestätigt | BofA/Merrill | Neutral |
| 2019-05-30 | Eingeleitet | Wolfe Research | Peer Perform |
| 2019-05-06 | Bestätigt | Needham | Strong Buy |
| 2019-05-03 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2019-05-03 | Hochstufung | UBS | Sell → Neutral |
| 2019-04-12 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2019-02-12 | Bestätigt | BTIG Research | Buy |
| 2019-01-03 | Eingeleitet | Needham | Strong Buy |
Alle ansehen
Bruker Corp Aktie (BRKR) Neueste Nachrichten
T. Rowe Price Investment Management Reduces Stake in Bruker Corp - GuruFocus.com
Bruker stock touches 52-week low at $54.55 amid market shifts - Investing.com
IR Spectroscopy Market to surpass USD 2 billion by 2032, Says Global Market Insights inc. - GlobeNewswire Inc.
Bruker's (NASDAQ:BRKR) Problems Go Beyond Weak Profit - Yahoo Finance
Polar Capital Holdings Plc Increases Stake in Bruker Corp - GuruFocus.com
FMR LLC Bolsters Stake in Bruker Corp - GuruFocus.com
Dragonfly Energy, Bruker Partner To Accelerate Battery Tech Development - RV PRO
Dragonfly Energy, Bruker Partner to Boost Battery Technology - RV Business
Dragonfly Energy and Bruker Partner to Accelerate Battery Technology Development - GlobeNewswire
Leerink Partnrs Issues Negative Outlook for Bruker Earnings - MarketBeat
Bruker Announces EpicIFTM, Revolutionary Fluorescence Signal Removal Technology, Transforming CellScape Spatial Proteomics Platform - Marketscreener.com
Kornitzer Capital Management Inc. KS Buys New Position in Bruker Co. (NASDAQ:BRKR) - MarketBeat
Bruker Co. (NASDAQ:BRKR) Receives $79.36 Consensus Price Target from Brokerages - MarketBeat
Bruker Corporation (NASDAQ:BRKR) Q3 2024 Earnings Call Transcript - Insider Monkey
FY2024 EPS Estimates for Bruker Reduced by Leerink Partnrs - MarketBeat
Bruker stock price target cut, hold rating sustained on Q3 performance - Investing.com
Bruker Analysts Cut Their Forecasts After Q3 Results - MSN
Earnings call: Bruker adjusts guidance amid biopharma, China challenges - Investing.com
Decoding 3 Analyst Evaluations For Bruker - Benzinga
Bruker (NASDAQ:BRKR) Price Target Cut to $69.00 by Analysts at Barclays - MarketBeat
Bruker Third Quarter 2024 Earnings: EPS Misses Expectations - Yahoo Finance
Bruker Corp (BRKR) Q3 2024 Earnings Call Highlights: Revenue Surge Amidst Margin Pressures - Yahoo Finance
Bruker Corp (BRKR) Q3 2024 Earnings Call Highlights: Revenue Sur - GuruFocus.com
JPMorgan cuts Bruker target to $80, maintains overweight - Investing.com
Bruker: Q3 Earnings Snapshot - The Washington Post
Bruker stock touches 52-week low at $54.74 amid market shifts - Investing.com
Bruker (NASDAQ:BRKR) Hits New 12-Month LowHere's Why - MarketBeat
Bruker (BRKR) Q3 Earnings and Revenues Lag Estimates - MSN
Bruker earnings matched, revenue fell short of estimates - Investing.com
Bruker falls after lowering FY profit forecast - XM
Bruker Corp Q3 2024 Earnings: Revenue Surpasses Estimates at $86 - GuruFocus.com
Bruker Reports Third Quarter 2024 Financial Results - Yahoo Finance
A Look Ahead: Bruker's Earnings Forecast - Benzinga
PineStone Asset Management Inc. Purchases 26,700 Shares of Bruker Co. (NASDAQ:BRKR) - MarketBeat
What Is Bruker Corporation's (NASDAQ:BRKR) Share Price Doing? - Yahoo Finance
Bruker (BRKR) Set to Announce Earnings on Tuesday - MarketBeat
Analysts Estimate Bruker (BRKR) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
Assenagon Asset Management S.A. Cuts Position in Bruker Co. (NASDAQ:BRKR) - MarketBeat
Bruker Announces Date and Time of Third Quarter 2024 Earnings Release and Webcast - Yahoo Finance
Bruker Announces One-Hundred Dollar, Deep, High-Accuracy Plasma Proteome; Advances Glycoproteomics and Metaproteomics – Company AnnouncementFT.com - Financial Times
BRKR Stock to Gain From Newly Formed Bruker Spatial Biology Division - MSN
Cwm LLC Purchases 9,165 Shares of Bruker Co. (NASDAQ:BRKR) - MarketBeat
YieldBoost Bruker From 0.3% To 19.8% Using Options - Nasdaq
Bruker wins patent case against 10x Genomics in Europe - Investing.com
European Unified Patent Court Rules in Favor of Bruker and NanoString, Invalidating Patent Asserted By 10x Genomics against NanoString’s CosMx SMI Products - Yahoo Finance
Rheos Capital Works Inc. Invests $3.45 Million in Bruker Co. (NASDAQ:BRKR) - MarketBeat
Is Bruker Corporation (BRKR) the Most Profitable Mid-Cap Stock to Invest In Now? - Insider Monkey
Bruker Corp (BRKR) Stock Price Down 3.06% on Oct 16 - GuruFocus.com
Bruker (NASDAQ:BRKR) Sees Strong Trading VolumeWhat's Next? - MarketBeat
Finanzdaten der Bruker Corp-Aktie (BRKR)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.38%
0.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):